![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Srf Limited Dahej In, based in India, is a pharmaceutical company.
One of their significant offerings is Norflurane, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2018-195 - Rev 00
This Chemical Type CEP, issued on May 20, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2257 associated with this CEP further emphasizes